Prosecution Insights
Last updated: May 29, 2026

Greenberg Traurig, LLP (Bos)

149 pending office actions • 80 clients • 137 examiners • 93 art units • 0 of 149 (0%) have an AI response strategy ready • 197 patents granted in the last 365 days

Portfolio Summary

149
Total Pending OAs
99
Non-Final OAs
47
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 148 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

75
Overdue
5
Due this week
41
Due this month
15
Due in next 60 days
12
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 148 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (75)Due ≤ 7 days (5)Due ≤ 30 days (41)Due ≤ 60 days (15)Due later (12)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (7%)
108
Medium (72%)
13
Easy (9%)
17
Unknown (11%)

Rejection Statute Mix

BucketCases
§101 only11 (7%)
§103 only93 (62%)
§102 only12 (8%)
§112 only13 (9%)
Double-patenting + other3 (2%)
No statute on record17 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

84
Life Sciences
56% of docket
19
Information Tech
13% of docket
3
Communications
2% of docket
2
Semiconductors
1% of docket
39
Mechanical / Eng
26% of docket
2
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,490 h
Manual time on pending OAs
298 h
Time saved (low, 20%)
522 h
Time saved (mid, 35%)
13.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
REGA, KYLE THOMAS 3 62.4% +43.9%
HENRY, THOMAS HAYNES 2 50.8% +37.4%
THOMAS, KAREEN KAY 2 76.7% +17.3%
HOPKINS, DAVID ANDREW 2 28.8% +35.5%
PATEL, MANGLESH M 2 74.3% +18.3%
LI, BAO Q 2 75.9% +26.2%
COLEMAN, CHARLES P. 2 16.0% +19.1%
BATES, KEENAN ALEXANDER 2 46.3% +70.8%
MOLOYE, TITILAYO 2 63.4% +47.1%
DEBERRY, REGINA M 2 49.8% +30.7%

Hard Cases (13)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17863459 Generating RTSM Systems for Clinical Trials COLEMAN, CHARLES P. 29d overdue
18827251 COMPUTER-BASED SYSTEM/PLATFORM CONFIGURED FOR NETWORK ACCESSIBLE VIRTUALLY SIMULATED LOCATIONS AND METHODS OF USE THEREOF HOPKINS, DAVID ANDREW 22d overdue
18683009 PERCEPTION TESTING PALMARCHUK, BRIAN KEITH 15d overdue
17852259 SYSTEMS AND METHODS FOR DEMAND AND SUPPLY FORECASTING FOR CLINICAL TRIALS KANAAN, MAROUN P 11d overdue
17769266 PREDICTION AND PLANNING FOR MOBILE ROBOTS PATEL, MANGLESH M 10d overdue
18657340 CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION CHERNYSHEV, OLGA N 8d overdue
17260041 METHODS FOR GENERATING BROADLY REACTIVE, PAN-EPITOPIC IMMUNOGENS, COMPOSITIONS AND METHODS OF USE THEREOF BLUMEL, BENJAMIN P 6d
15418363 SELF-IMPROVING METHOD OF USING ONLINE COMMUNITIES TO PREDICT HEALTH-RELATED OUTCOMES HAYES, JONATHAN EDWARD 12d

Interview Candidates (21)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17709136 NEURAL ORGANOID COMPOSITION AND METHODS OF USE MOLOYE, TITILAYO 80d overdue
17765796 MICROGLIA SPECIFIC PROMOTERS AND METHODS OF USE THEREFORE BATES, KEENAN ALEXANDER 78d overdue
17965257 CUSTOM AUTOLOGOUS VACCINE COMPOSITION, AND A METHOD FOR ITS MANUFACTURE MOLOYE, TITILAYO 77d overdue
17906730 VEGF DIMER MOLECULES AND COLUMNS COMPRISING A VEGF DIMER MOLECULE AS WELL AS USES, PRODUCTION METHODS AND METHODS INVOLVING THE SAME DEBERRY, REGINA M 31d overdue
17863459 Generating RTSM Systems for Clinical Trials COLEMAN, CHARLES P. 29d overdue
17267947 COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT REGA, KYLE THOMAS 23d overdue
18827251 COMPUTER-BASED SYSTEM/PLATFORM CONFIGURED FOR NETWORK ACCESSIBLE VIRTUALLY SIMULATED LOCATIONS AND METHODS OF USE THEREOF HOPKINS, DAVID ANDREW 22d overdue
17769266 PREDICTION AND PLANNING FOR MOBILE ROBOTS PATEL, MANGLESH M 10d overdue

Client Portfolio (80 clients)

Client (Assignee)Pending OAs
Five AI 20
DataRobot 9
THE CHILDREN'S MEDICAL CENTER CORPORATION 8
DANA-FARBER CANCER INSTITUTE, INC. 7
CHILDREN'S MEDICAL CENTER CORPORATION 6
Universal Sequencing Technology Corporation 4
West Texas Technology Partners, LLC 3
Aerin Medical Inc. 3
Formlabs 3
University of Memphis 3
Harvard University 3
4G CLINICAL, LLC 3
ImagineAR 2
Origin Materials Operating, Inc. 2
HDT Bio 2
UNIVERSITEIT LEIDEN 2
Clarapath 2
Sensome SAS 2
U.S. Government 2
UMC UTRECHT HOLDING B.V. 2
Aspira Women's Health 2
Novel Biotechnology USA, Inc. 1
Outer Biosciences, Inc. 1
Cantai Therapeutics 1
Thomas J.C. Matzen GMBH 1
Riverlane Ltd 1
Girish KRISHNAMURTHY 1
Magnomer, Inc. 1
InMobi Pte Ltd. 1
Equilibria Group Inc. 1
Incantio Inc. 1
Johns Hopkins 1
Plantible Foods Inc. 1
PNEUMAX, LLC 1
Bionova Medical, Inc. 1
Worcester Polytechnic Institute 1
SMK CORPORATION 1
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 1
Rontis Hellas S.A. 1
Atacama Biomaterials 1
Arix Technologies 1
THE GENERAL HOSPITAL CORPORATION 1
Cydex Pharmaceuticals, Inc. 1
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1
RHODE ISLAND HOSPITAL 1
Tigatx 1
GALVENTA AG 1
460Medical 1
Covid Cough 1
University of California 1
Spark Assets LLC 1
Ear Science Institute Australia 1
Arizona State University 1
Gretap AG 1
MDI Biological Laboratory 1
SALK INSTITUTE FOR BIOLOGICAL STUDIES 1
Trividia Health, Inc. 1
Stellular Bio, Inc. 1
Havells India Limited 1
InfraSalience Ltd. 1
Intima Bioscience, Inc. 1
Athergen 1
UNIVERSITÄT ZU KÖLN 1
Vai Photonics Pty Ltd. 1
Tiga TX, Inc. 1
Deutsches Krebsforschungszentrum 1
Rene ANAND 1
Edifice Health, Inc, 1
NEWMEDICAL TECHNOLOGY, INC. 1
Accure Health 1
Medici Therapeutics, Inc. 1
THEMBA INC. 1
Case Western Reserve University 1
ORIGIN PEPTIDES LIMITED 1
OXFORD UNIVERSITY INNOVATION LIMITED 1
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 1
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 1
CAMBRIDGE ENTERPRISE LIMITED 1
PROMEND ANIMAL HEALTH, INC. 1
PatientsLikeMe LLC 1

Top Art Units

Art UnitApps
16365
16325
16824
16314
16474
16413
16853
36583
37943
16813

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19343343 EXPRESSION SYSTEM FOR PRODUCT MANUFACTURING Novel Biotechnology USA, Inc. LEITH, NANCY J 1636 Other Non-Final OA 12d Pending Sep 29, 2025
19320607 SYSTEMS AND PROCESSES FOR SKIN TISSUE GROWTH AND ANALYSIS Outer Biosciences, Inc. HASSAN, LIBAN M 1799 §103 Final Rejection 16d Pending Sep 05, 2025
19238328 ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE Cantai Therapeutics Inc. DAHLE, CHUN WU 1641 §103 Final Rejection 51d overdue Pending Jun 13, 2025
19236435 METHOD AND DEVICES FOR AGE DETERMINATION Thomas J.C. Matzen GmbH BICKHAM, DAWN MARIE 1685 Other Final Rejection 19d Pending Jun 12, 2025
19176364 SYSTEMS AND METHODS FOR CAPTURE AND USE OF LOCAL ELEMENTS IN GAMEPLAY Imaginear, Inc. HENRY, THOMAS HAYNES 3715 §102 Non-Final OA 30d Pending Apr 11, 2025
19175119 SYSTEMS AND METHODS FOR CAPTURE AND USE OF LOCAL ELEMENTS IN GAMEPLAY Imaginear, Inc. HENRY, THOMAS HAYNES 3715 §102 Non-Final OA 54d Pending Apr 10, 2025
19044855 Quantum Error Correction with Leakage Riverlane Ltd. PATEL, JIGAR P 2114 §103 Final Rejection 84d overdue Pending Feb 04, 2025
18878829 SYSTEM AND METHOD FOR PROVIDING A TRUE HEALTH-WELLNESS STATUS OF A USER Girish Krishnamurthy PORTER, RACHEL L 3684 §103 Non-Final OA 50d overdue Pending Dec 24, 2024
18874182 MOTION PREDICTION FOR MOBILE AGENTS Five AI Limited CAMBY, RICHARD M 3661 §102 Non-Final OA 9d Pending Dec 12, 2024
18978623 METHODS AND COMPOSITIONS FOR MAGNETIZABLE PLASTICS Magnomer, Inc. YOUNG, WILLIAM D 1761 §103 Final Rejection Pending Dec 12, 2024
18975575 Methods and Apparatuses for Applying Free Space Inputs for Surface Constrained Controls West Texas Technology Partners, LLC JOHNSON, GERALD 3797 §103 Non-Final OA 91d overdue Pending Dec 10, 2024
18962407 AUGMENTED REALITY TASK FLOW OPTIMIZATION SYSTEMS West Texas Technology Partners, LLC MILLER, ALAN S 3625 Other Non-Final OA 42d Pending Nov 27, 2024
18960245 METHOD AND SYSTEM OF INITIATING AN ACTION BASED ON AN ATTENTION CATEGORY Inmobi Pte. Ltd. DURAN, ARTHUR D 3622 §103 Final Rejection 2d overdue Pending Nov 26, 2024
18904683 POLYESTER RESIN CLOSURES FOR CONTAINERS Origin Materials Operating, Inc. THOMAS, KAREEN KAY 3736 §103 Non-Final OA 84d Pending Oct 02, 2024
18904689 POLYESTER RESIN CLOSURES FOR CONTAINERS Origin Materials Operating, Inc. THOMAS, KAREEN KAY 3736 §103 Final Rejection 84d Pending Oct 02, 2024
18827251 COMPUTER-BASED SYSTEM/PLATFORM CONFIGURED FOR NETWORK ACCESSIBLE VIRTUALLY SIMULATED LOCATIONS AND METHODS OF USE THEREOF Equilibria Group Inc. HOPKINS, DAVID ANDREW 2188 §103 Non-Final OA 22d overdue Pending Sep 06, 2024
18801663 SYSTEMS AND METHODS FOR DEVELOPMENT, ASSESSMENT, AND/OR MONITORING OF A GENERATIVE AI SYSTEM Datarobot, Inc. PYO, MONICA M 2161 §103 Non-Final OA 28d Pending Aug 12, 2024
18835554 TRAJECTORY GENERATION FOR MOBILE AGENTS Five AI Limited GONZALEZ, MARIO CARLOS 3668 §103 Non-Final OA 71d Pending Aug 02, 2024
18787894 DATA ANALYTICS METHODS FOR SPATIAL DATA, AND RELATED SYSTEMS AND DEVICES Datarobot, Inc. SAMARA, HUSAM TURKI 2161 §103 Non-Final OA 53d overdue Pending Jul 29, 2024
18728430 MOTION PREDICTION AND TRAJECTORY GENERATION FOR MOBILE AGENTS Five AI Limited STIEBRITZ, NOAH WILLIAM 3658 §103 Final Rejection 22d Pending Jul 11, 2024
18748808 Method and Apparatus for Switching Between Sensors West Texas Technology Partners, LLC MANIWANG, JOSEPH R 2441 Other Non-Final OA 43d overdue Pending Jun 20, 2024
18742965 DRIVING SCENARIOS FOR AUTONOMOUS VEHICLES Five AI Limited MELTON, TODD M 3669 §103 Non-Final OA 9d overdue Pending Jun 13, 2024
18740252 NASAL AIRWAY TISSUE TREATMENT SYSTEM AND METHOD Aerin Medical Inc. BOCK, ABIGAIL MARIE 3794 §103 Non-Final OA 56d Pending Jun 11, 2024
18737704 CHARACTERISTIC-BASED MEDIA ANALYSIS AND SEARCH Incantio Inc. ALLEN, BRITTANY N 2169 §103 Final Rejection 2d overdue Pending Jun 07, 2024
18737401 ETHMOIDAL NERVE TREATMENT SYSTEM AND METHOD Aerin Medical Inc. SHOULDERS, ANNIE LEE 3794 §103 Non-Final OA 34d Pending Jun 07, 2024
18657340 CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION The Johns Hopkins University CHERNYSHEV, OLGA N 1675 §101 Final Rejection 8d overdue Pending May 07, 2024
18701206 ROAD LAYOUT INDEXING AND QUERYING Five AI Limited AFRIN, NAZIA 3666 §103 Final Rejection 26d Pending Apr 12, 2024
18634139 USING RIBULOSE-1,5-BISPHOSPHATE CARBOXYLATE-OXYGENASE (RUBISCO) ISOLATE AS A FAT BINDING AGENT Plantible Foods Inc. YOO, HONG THI 1792 §103 Non-Final OA 27d Pending Apr 12, 2024
18612850 COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN BINDING PROTEINS Hdt Bio Corp. VYAS, KEYUR ANILKUMAR 1637 §103 Non-Final OA 36d overdue Pending Mar 21, 2024
18581519 RECOATING TECHNIQUES FOR POWDER-BASED ADDITIVE FABRICATION AND RELATED SYSTEMS AND METHODS Formlabs, Inc. MORENO HERNANDEZ, JERZI H 1743 §103 Non-Final OA 11d overdue Pending Feb 20, 2024
18442786 METHODS FOR SELF-ADAPTIVE TIME SERIES FORECASTING, AND RELATED SYSTEMS AND APPARATUS Datarobot, Inc. HOTALING, JOHN M 3992 §103 Non-Final OA 60d overdue Pending Feb 15, 2024
18683399 SYSTEMS AND METHODS FOR REAL-TIME ANALYSIS OF INHALED PARTICLES Pneumax, LLC BRYANT, REBECCA CAROLE 2877 §112 Non-Final OA 49d overdue Pending Feb 13, 2024
18683009 PERCEPTION TESTING Five Al Limited PALMARCHUK, BRIAN KEITH 3669 §101 Final Rejection 15d overdue Pending Feb 12, 2024
18293246 PERCEPTION OF 3D OBJECTS IN SENSOR DATA Five AI Limited BARHAM, RYAN ALLEN 2613 §103 Non-Final OA 9d overdue Pending Jan 29, 2024
18420626 TECHNIQUES FOR ADDITIVE FABRICATION UTILIZING LCD AND/OR LED LIGHT SOURCES AND RELATED SYSTEMS AND METHODS Formlabs, Inc. SMITH JR., JIMMY R 1745 §103 Non-Final OA 46d overdue Pending Jan 23, 2024
18291540 ESTIMATING DIAGNOSTIC QUALITY OF IMAGE FROM MR SIGNALS Children’S Medical Center Corporation ROBINSON, NICHOLAS A 3798 §103 Final Rejection 50d overdue Pending Jan 23, 2024
18399092 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER DANA-FARBER CANCER INSTITUTE, INC. YOO, SUN JAE 1621 §102 Final Rejection 26d overdue Pending Dec 28, 2023
18391074 BIOPOLYMER SCAFFOLDS AND METHODS FOR PRODUCTION OR USE THEREOF Bionova Medical, Inc. FUBARA, BLESSING M 1613 §102 Non-Final OA 19d overdue Pending Dec 20, 2023
18564300 TOOLS FOR PERFORMANCE TESTING AUTONOMOUS VEHICLE PLANNERS Five Al Limited AGUILERA, TODD 2192 §103 Final Rejection 15d Pending Nov 27, 2023
18562133 ADVERSARIAL ATTACKS ON PERCEPTION COMPONENTS Five AI Limited LOPEZ, MIGUEL ALEXANDER 2496 §103 Non-Final OA 46d overdue Pending Nov 17, 2023
18508058 BIOMIMETIC LIPOSOMES AND METHODS OF MAKING AND USING THE SAME Worcester Polytechnic Institute KWON, JOHN SEUNGJAI 1615 §103 Non-Final OA 15d Pending Nov 13, 2023
18506380 CUSTOMIZABLE AUTOMATED MACHINE LEARNING SYSTEMS AND METHODS Datarobot, Inc. ALKHATEEB, NOOR 2193 §103 Non-Final OA 13d Pending Nov 10, 2023
18506415 SYSTEMS AND METHODS FOR VISUALIZING MACHINE INTELLIGENCE Datarobot, Inc. LE, JOHN H 2857 §103 Non-Final OA 13d Pending Nov 10, 2023
18495588 TECHNIQUES FOR SPEECH LANGUAGE MODEL TRAINING AND APPLICATION Smk Corporation ALBERTALLI, BRIAN LOUIS 2656 §103 Non-Final OA 2d overdue Pending Oct 26, 2023
18494528 COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS The Brigham And Women'S Hospital, Inc. TURPIN, ZACHARY MARK 1682 §103 Non-Final OA 4d overdue Pending Oct 25, 2023
18556142 Drug Delivery System for Medical Devices Rontis Hellas S.A. MERCIER, MELISSA S 1615 §103 Non-Final OA 14d Pending Oct 19, 2023
18486052 3D Printed Meshes For Filters Based on Digitally Designed Lattice-Based Cellular Microarchitectures Atacama Biomaterials Inc. KASENGE, CHARLES R 2116 §103 Non-Final OA 70d overdue Pending Oct 12, 2023
18553278 INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) UNIVERSITEIT LEIDEN KRISHNAN, GANAPATHY 1693 §103 Non-Final OA 28d overdue Pending Sep 29, 2023
18375286 PIPE TRAVERSING APPARATUS, SENSING, AND CONTROLS Arix Technologies, Inc. JOS, BASIL T 3658 §103 Non-Final OA 56d overdue Pending Sep 29, 2023
18468298 COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS The General Hospital Corporation KIM, YOUNG J 1681 §103 Non-Final OA 83d Pending Sep 15, 2023
18244141 INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME Cydex Pharmaceuticals, Inc. ARNOLD, ERNST V 1613 §103 Non-Final OA 5d overdue Pending Sep 08, 2023
18279773 SIMULATION BASED TESTING FOR TRAJECTORY PLANNERS Five Al Limited BOURZIK, BRAHIM 2191 §103 Non-Final OA 35d overdue Pending Aug 31, 2023
18241186 SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA DANA-FARBER CANCER INSTITUTE, INC. JARRELL, NOBLE E 1699 Other Non-Final OA 32d overdue Pending Aug 31, 2023
18276952 PREDICTION AND PLANNING FOR MOBILE ROBOTS Five AI Limited PATEL, MANGLESH M 3665 §103 Final Rejection 9d Pending Aug 11, 2023
18362634 CANCER-SELECTIVE TARGET DEGRADATION BY TARGETING GROUP CAGED PROTACS Icahn School Of Medicine AT Mount Sinai DAHLIN, HEATHER RAQUEL 1629 §103 Non-Final OA 105d overdue Pending Jul 31, 2023
18275180 VEHICLE TRAJECTORY ASSESSMENT Five AI Limited PEDERSEN, DAVID RUBEN 3658 §103 Non-Final OA 22d Pending Jul 31, 2023
18274279 IMAGE-BASED APPROACH TO EVALUATE CONNECTIVE TISSUE STRUCTURE, REMODELING, AND RISK OF INJURY Rhode Island Hospital MAYNARD, JOHNATHAN A 3798 §103 Non-Final OA 14d Pending Jul 26, 2023
18274167 GENERATING SIMULATION ENVIRONMENTS FOR TESTING AV BEHAVIOUR Five AI Limited BERMAN, STEPHEN DAVID 2192 §103 Final Rejection 73d overdue Pending Jul 25, 2023
18223761 AUTOMATIC SMOOTHING AND RE-BINNING FOR MACHINE LEARNING MODEL OUTPUT Datarobot, Inc. NGUYEN, MAIKHANH 2144 §103 Non-Final OA 19d Pending Jul 19, 2023
18272950 EXTRACTING FEATURES FROM SENSOR DATA Five Al Limited MCLEAN, NEIL R 2681 §103 Non-Final OA 22d Pending Jul 18, 2023
18272773 RADAR PERCEPTION Five AI Limited WOLFORD, NAOMI M 3648 §103 Non-Final OA 8d overdue Pending Jul 17, 2023
18349562 Engineered EpCam Binding Antibodies Tigatx SULLIVAN, DENNIS JOHN 1642 §112 Non-Final OA 70d Pending Jul 10, 2023
18271088 PULSATILE RELEASE CAFFEINE FORMULATION Galventa AG MOU, LIYUAN 1628 §103 Non-Final OA 23d overdue Pending Jul 06, 2023
18341584 COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT The Children's Hospital of Philadelphia ANDERSON, JAMES D 1629 Non-Final OA 171d overdue Pending Jun 26, 2023
18210925 MAGNETIC CATHETER 460Medical, Inc. WOO, JAE KYUN 3795 §103 Final Rejection 34d Pending Jun 16, 2023
18204108 MACHINE LEARNING MODEL SEARCH USING META DATA Datarobot, Inc. LU, HWEI-MIN 2142 §112 Non-Final OA 10d overdue Pending May 31, 2023
18315849 SYSTEMS AND METHODS FOR ACOUSTIC FEATURE EXTRACTION AND DUAL SPLITTER MODEL Covid Cough, Inc. NEURAUTER JR, GEORGE C 2459 §112 Non-Final OA 45d overdue Pending May 11, 2023
18315472 N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER DANA-FARBER CANCER INSTITUTE, INC. WILLIS, DOUGLAS M 1624 §103 Final Rejection 70d Pending May 10, 2023
18313158 ADENO-ASSOCIATED VIRUS VECTORS The Children's Hospital of Philadelphia LI, BAO Q 1671 §103 Non-Final OA 40d Pending May 05, 2023
18311075 SONOGENETIC MODULATION OF CELLS EXPRESSING BACTERIALLY-DERIVED MECHANOSENSITIVE PROTEINS The Regents of the University of California ROONEY, NORA MAUREEN 1641 §102 Non-Final OA 42d Pending May 02, 2023
18308455 Piezoelectric Orthopedic Implant and Methodology Spark Assets LLC GIBSON, ERIC SHANE 3775 §103 Non-Final OA 99d overdue Pending Apr 27, 2023
18032051 METHODS FOR GENERATING INNER EAR HAIR CELLS Ear Science Institute Australia BEHARRY, ZANNA MARIA 1632 §103 Final Rejection 70d Pending Apr 14, 2023
18298922 TRANSMEMBRANE NANOSENSOR ARRAYS FOR RAPID, ULTRA-SENSITIVE AND SPECIFIC DIGITAL QUANTIFICATION OF INTERNAL MICRO-RNA CONTENT OF INTACT EXOSOMES Arizona Board of Regents BUCHANAN, BAILEY CHEYENNE 1682 Other Non-Final OA 7d Pending Apr 11, 2023
18132746 COMPOSITIONS AND METHODS FOR THE DETECTION AND MOLECULAR PROFILING OF MEMBRANE BOUND VESICLES WITH NANOPARTICLES The University of Memphis Research Foundation NGUYEN, NAM P 1678 §103 Non-Final OA 12d Pending Apr 10, 2023
18131659 MEDICAL DEVICE FOR STIMULATING NEURONS OF A PATIENT TO SUPPRESS A PATHOLOGICALLY SYNCHRONOUS ACTIVITY THEREOF Gretap AG EDWARDS, PHILIP CHARLES 3792 §103 Final Rejection 63d Pending Apr 06, 2023
18127516 METHOD, SYSTEM, AND DEVICE FOR AUTOMATING TRANSFER OF TAPE TO MICROTOME SECTIONS Clarapath, Inc. WHATLEY, BENJAMIN R 1798 DPOther Non-Final OA 70d Pending Mar 28, 2023
18022948 BROMODOMAIN AND EXTRA TERMINAL DOMAIN (BET) INHIBITOR COMPOSITIONS AND METHODS THEREOF FOR USE AS ANTI-AGING AGENTS Mdi Biological Laboratory RODRIGUEZ, RAYNA B 1628 §103 Non-Final OA 19d overdue Pending Feb 23, 2023
18020587 COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA President and Fellows of Harvard College GOLDBERG, JEANINE ANNE 1682 §102 Non-Final OA 31d overdue Pending Feb 09, 2023
18105651 INSERTABLE DEVICE FOR IN VIVO SENSING Sensome SAS HENSON, DEVIN B 3791 §103 Non-Final OA 46d overdue Pending Feb 03, 2023
18100388 AUTOMATED RANDOMIZATION VALIDATION FOR AN RTSM SYSTEM 4G Clinical, LLC COLEMAN, CHARLES P. 3683 §101 Non-Final OA 29d Pending Jan 23, 2023
18016251 SONOGENETIC STIMULATION OF CELLS EXPRESSING TRPA1 Salk Institute For Biological Studies BATES, KEENAN ALEXANDER 1631 Other Non-Final OA 9d Pending Jan 13, 2023
18149397 Methods and Kits for Tracking Nucleic Acid Target Origin for Nucleic Acid Sequencing Universal Sequencing Technology Corporation DAUNER, JOSEPH G 1682 §103 Non-Final OA 121d overdue Pending Jan 03, 2023
18078639 SYSTEM AND METHOD TO GENERATE A USER INTERFACE PRESENTING A PREDICITION OR EXPLANATION OF INPUT DATA HAVING A TIME SERIES DEPENDENCY OR A GEOSPATIAL DEPENDENCY Datarobot, Inc. NGUYEN, NHAT HUY T 2147 §103 Non-Final OA 32d overdue Pending Dec 09, 2022
18009645 USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS The Children's Hospital of Philadelphia HUTTER, GILLIAN A 1625 §103 Non-Final OA 1d overdue Pending Dec 09, 2022
18008070 TESTING AND SIMULATION IN AUTONOMOUS DRIVING Five AI Limited BONSHOCK, DENNIS G 3992 §103 Final Rejection 71d Pending Dec 02, 2022
18061369 COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA DANA-FARBER CANCER INSTITUTE, INC. SHELTON, SYNPHANE LA'SHAWN 1652 §112 Non-Final OA 26d Pending Dec 02, 2022
18008127 OPERATIONAL DESIGN DOMAINS IN AUTONOMOUS DRIVING Five AI Limited JOHNSON, CEDRIC D 2186 §103 Non-Final OA 7d Pending Dec 02, 2022
18008145 SIMULATION IN AUTONOMOUS DRIVING Five AI Limited HOPKINS, DAVID ANDREW 2188 §103 Non-Final OA 27d Pending Dec 02, 2022
18072496 SYSTEMS AND METHODS FOR HEMATOCRIT IMPEDANCE MEASUREMENT USING 4-WIRE MEASUREMENT Trividia Health, Inc. KWAK, DEAN P 1798 §103 Non-Final OA 112d overdue Pending Nov 30, 2022
17992894 AUTOMATED TISSUE SECTION SYSTEM WITH THICKNESS CONSISTENCY CONTROLS Clarapath, Inc. SHI, TINGCHEN 1796 §103 Non-Final OA 74d overdue Pending Nov 22, 2022
17990406 MEDICAL DEVICE PROVIDED WITH SENSORS Sensome SAS PATEL, AREN 3774 §103 Non-Final OA 7d Pending Nov 18, 2022
17985365 NOVEL ANUCLEATED CELLS AS A SOURCE FOR TREATMENT OF PLATELET RICH PLASMA DEPENDENT DISORDERS Stellular Bio, Inc. REGLAS, GILLIAN CHELSEA 1632 Other Non-Final OA 44d overdue Pending Nov 11, 2022
17923872 METHODS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISORDERS President and Fellows of Harvard College YOUTCHOM PENDIE, EMMANUEL LED 1647 §103 Non-Final OA 126d overdue Pending Nov 07, 2022
18051701 POLYOLEFIN BASED DIFFUSER FOR LIGHTING FIXTURES Havells India Limited DILLON, DANIEL P 1783 §103 Non-Final OA 30d Pending Nov 01, 2022
18048613 Ammonia Synthesis System and Method Infrasalience Ltd. DOWNES, NATHANAEL JASON 1794 §103 Non-Final OA 26d Pending Oct 21, 2022
18048230 CELLULAR VACCINE PLATFORM AND METHODS OF USE Intima Bioscience, Inc. JUEDES, AMY E 1644 Other Non-Final OA 113d overdue Pending Oct 20, 2022
18047715 METHODS AND DEVICES TO TREAT NASAL AIRWAYS Aerin Medical Inc. PEFFLEY, MICHAEL F 3794 §103 Final Rejection 9d overdue Pending Oct 19, 2022
17965257 CUSTOM AUTOLOGOUS VACCINE COMPOSITION, AND A METHOD FOR ITS MANUFACTURE Athergen, Inc. MOLOYE, TITILAYO 1632 §103 Final Rejection 77d overdue Pending Oct 13, 2022
17918807 APPROXIMATION DEVICE Children'S Medical Center Corporation WOODALL, NICHOLAS W 3775 §102 Final Rejection 57d Pending Oct 13, 2022
17915911 COMPUTER-BASED SYSTEMS AND DEVICES CONFIGURED FOR DEEP LEARNING FROM SENSOR DATA NON-INVASIVE SEIZURE FORECASTING AND METHODS THEREOF The Children's Hospital of Philadelphia MALAMUD, DEBORAH LESLIE 3792 §103 Non-Final OA 4d overdue Pending Sep 29, 2022
17955161 VEHICLE LOCALIZATION Five AI Limited WU, PAYSUN 3665 §103 Non-Final OA 14d Pending Sep 28, 2022
17934553 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER DANA-FARBER CANCER INSTITUTE, INC. BRAUN, MADELINE E 1624 §102 Final Rejection 79d overdue Pending Sep 22, 2022
17906730 VEGF DIMER MOLECULES AND COLUMNS COMPRISING A VEGF DIMER MOLECULE AS WELL AS USES, PRODUCTION METHODS AND METHODS INVOLVING THE SAME UNIVERSITÄT ZU KÖLN DEBERRY, REGINA M 1647 §103 Non-Final OA 31d overdue Pending Sep 19, 2022
17942458 SYSTEMS AND METHODS OF GENERATING AND VALIDATING TIME-SERIES FEATURES USING MACHINE LEARNING Datarobot, Inc. BREEN, JAKE TIMOTHY 2143 §101 Final Rejection 21d Pending Sep 12, 2022
17759742 MACROMOLECULES ENGINEERED FOR NANOELECTRONIC MEASUREMENT Universal Sequencing Technology Corporation GAO, ASHLEY HARTMAN 1678 Other Non-Final OA 128d overdue Pending Jul 29, 2022
17794895 ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE The Children's Hospital of Philadelphia AMICK, THOMAS RUSSE 1638 §103 Non-Final OA 17d overdue Pending Jul 22, 2022
17863459 Generating RTSM Systems for Clinical Trials 4G Clinical, LLC COLEMAN, CHARLES P. 3683 §101 Final Rejection 29d overdue Pending Jul 13, 2022
17852259 SYSTEMS AND METHODS FOR DEMAND AND SUPPLY FORECASTING FOR CLINICAL TRIALS 4G Clinical, LLC KANAAN, MAROUN P 3687 §101 Final Rejection 11d overdue Pending Jun 28, 2022
17788664 LIDAR APPARATUS AND PROCESS Vai Photonics Pty Ltd. VASQUEZ JR, ROBERT WILLIAM 3645 §103 Final Rejection 70d Pending Jun 23, 2022
17841326 ENGINEERED ANTIBODIES AND METHODS OF TREATMENT Tiga TX, Inc. WEN, SHARON X 1641 DPOther Non-Final OA 70d Pending Jun 15, 2022
17750061 CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS LEE, JAE W 1656 §102 Non-Final OA 14d Pending May 20, 2022
17769266 PREDICTION AND PLANNING FOR MOBILE ROBOTS Five AI Limited PATEL, MANGLESH M 3665 §101 Non-Final OA 10d overdue Pending Apr 14, 2022
17767340 METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA The Children's Hospital of Philadelphia MCLEOD, AFRICA MHAIRIE 1635 Other Final Rejection 89d overdue Pending Apr 07, 2022
17765796 MICROGLIA SPECIFIC PROMOTERS AND METHODS OF USE THEREFORE DANA-FARBER CANCER INSTITUTE, INC. BATES, KEENAN ALEXANDER 1631 Other Non-Final OA 78d overdue Pending Mar 31, 2022
17709136 NEURAL ORGANOID COMPOSITION AND METHODS OF USE Rene Anand MOLOYE, TITILAYO 1632 Final Rejection 80d overdue Pending Mar 30, 2022
17764917 COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE DANA-FARBER CANCER INSTITUTE, INC. LEONARD, ARTHUR S 1631 DPOther Final Rejection 60d Pending Mar 29, 2022
17761371 AN ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINE AND METHODS OF USE Children'S Medical Center Corporation LI, BAO Q 1671 Other Non-Final OA 14d Pending Mar 17, 2022
17761376 Antibiotic Compounds UNIVERSITEIT LEIDEN CREWS, JARET JAMES 1691 §112 Non-Final OA 7d Pending Mar 17, 2022
17680931 Gene Expression Inflammatory Age and Its Uses Edifice Health, Inc., SCHLOOP, ALLISON ELIZABETH 1683 §101 Non-Final OA 54d Pending Feb 25, 2022
17636590 Methods and Compositions for Tracking Nucleic Acid Fragment Origin for Nucleic Acid Sequencing Universal Sequencing Technology Corporation CHUNDURU, SURYAPRABHA 1681 §102 Final Rejection 80d overdue Pending Feb 18, 2022
17674378 INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY The United States Department of Health and Human Services LEONARD, ARTHUR S 1631 §103 Final Rejection 23d overdue Pending Feb 17, 2022
17583431 Systems and Methods for Making Hydrophilic Foams Newmedical Technology, Inc. COONEY, JOHN M 1765 §103 Final Rejection 17d overdue Pending Jan 25, 2022
17622611 PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY Accure Health Inc. MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 85d overdue Pending Dec 23, 2021
17596182 Methods of Barcoding Nucleic Acid for Detection and Sequencing Universal Sequencing Technology Corporation YOUNG, BRIAN ELLIS 1684 §102 Final Rejection 98d overdue Pending Dec 03, 2021
17615857 LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID DELIVERY Medici Therapeutics, Inc. KOMATSU, LI N 1658 Other Non-Final OA 55d Pending Dec 02, 2021
17478615 MODIFIED CELLS AND METHODS OF THERAPY The United States Department of Health and Human Services WEHBE, ANNE MARIE SABRINA 1634 §112 Non-Final OA 28d Pending Sep 17, 2021
17440548 USING RELATIVES' INFORMATION TO DETERMINE GENETIC RISK FOR NON-MENDELIAN PHENOTYPES Themba Inc. FURTADO, WINSTON RAHUL 3687 §101 Final Rejection 14d Pending Sep 17, 2021
17427394 COST-EFFECTIVE DETECTION OF LOW FREQUENCY GENETIC VARIATION Children'S Medical Center Corporation GIAMMONA, FRANCESCA FILIPPA 1681 §103 Final Rejection 19d Pending Jul 30, 2021
17425272 COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS The Children's Hospital of Philadelphia WHITEMAN, BRIAN A 1636 §103 Non-Final OA 29d Pending Jul 22, 2021
17350007 TECHNIQUES FOR POWDER TAGGING IN ADDITIVE FABRICATION AND RELATED SYSTEMS AND METHODS Formlabs, Inc. KUMAR, SRILAKSHMI K 1700 §103 Final Rejection 86d overdue Pending Jun 17, 2021
17331375 BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE Case Western Reserve University KREMER, MATTHEW 3791 §112 Non-Final OA 30d overdue Pending May 26, 2021
17309150 PEPTIDE SYNTHESIS Origin Peptides Limited KATAKAM, SUDHAKAR 1658 §112 Non-Final OA 26d Pending Apr 30, 2021
17242954 IgA mediated killing of aberrant cells by CD47- SIRPalpha checkpoint inhibition of neutrophils UMC Utrecht Holding B.V. DEBERRY, REGINA M 1647 §112 Non-Final OA 34d Pending Apr 28, 2021
17242793 COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS UMC Utrecht Holding B.V. ALLEN, MARIANNE P 1647 §112 Non-Final OA 27d Pending Apr 28, 2021
17273467 Method or System for Identification of a Causative Mutation Causing a Phenotype of Interest in a Test Sample Oxford University Innovation Limited STRIEGEL, THEODORE CHARLES 1685 §112 Non-Final OA 33d Pending Mar 04, 2021
17267947 COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT Aspira Women's Health Inc. REGA, KYLE THOMAS 1636 §112 Final Rejection 23d overdue Pending Feb 11, 2021
17159766 Systems and Methods for Early Detection of Fracture Healing BETH ISRAEL DEACONESS MEDICAL CENTER, INC. HANEY, JONATHAN MICHAEL 3791 §103 Non-Final OA 4d overdue Pending Jan 27, 2021
17260041 METHODS FOR GENERATING BROADLY REACTIVE, PAN-EPITOPIC IMMUNOGENS, COMPOSITIONS AND METHODS OF USE THEREOF UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. BLUMEL, BENJAMIN P 1671 §101 Final Rejection 6d Pending Jan 13, 2021
17058046 METHODS FOR TREATING SPINAL CORD INJURY The Children's Hospital of Philadelphia CHONG, YONG SOO 1623 §103 Final Rejection 22d Pending Nov 23, 2020
17045412 COMPOSITIONS AND METHODS FOR SOMATIC CELL REPROGRAMMING AND MODULATING IMPRINTING Children'S Medical Center Corporation BERTOGLIO, VALARIE E 1632 Other Final Rejection 52d overdue Pending Oct 05, 2020
16979084 COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS Children'S Medical Center Corporation LEE, ANDREW P 1691 §103 Non-Final OA 128d overdue Pending Sep 08, 2020
16984885 COMPOSITIONS AND METHODS FOR IDENTIFYING A SINGLE-NUCLEOTIDE VARIANT President and Fellows of Harvard College REGA, KYLE THOMAS 1636 §103 Final Rejection 34d Pending Aug 04, 2020
16964733 CONJUGATABLE DESMOGLEIN 2 (DSG2) BINDING PROTEINS AND USES THEREFOR Hdt Bio Corp. HARTLEY, MICHAEL G 1618 §103 Final Rejection 23d overdue Pending Jul 24, 2020
16963809 COMPOSITIONS AND METHODS FOR REGULATING A BIOLOGICAL PROCESS The University of Memphis Research Foundation REGA, KYLE THOMAS 1636 §103 Non-Final OA 54d Pending Jul 21, 2020
16794723 Transcription Factor Mediated Programming Towards Megakaryocytes Cambridge Enterprise Limited CONNORS, ALEXANDRA F 1634 §103 Non-Final OA 14d Pending Feb 19, 2020
16793347 PREDICTIVE BIOMARKERS FOR OVARIAN CANCER Aspira Women's Health Inc. BARRON, SEAN C 1653 §103 Non-Final OA 23d Pending Feb 18, 2020
16619778 COMPOSITIONS AND METHODS FOR TREATING WOUNDS Promend Animal Health, Inc. BOECKELMAN, JACOB A 1655 §103 Non-Final OA 25d overdue Pending Dec 05, 2019
16334542 MICROBEAD COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT The University of Memphis Research Foundation ALLEY, GENEVIEVE S 1617 §103 Final Rejection 20d Pending Mar 19, 2019
15418363 SELF-IMPROVING METHOD OF USING ONLINE COMMUNITIES TO PREDICT HEALTH-RELATED OUTCOMES Patientslikeme LLC HAYES, JONATHAN EDWARD 1685 §101 Non-Final OA 12d Pending Jan 27, 2017

Managing Greenberg Traurig, LLP (Bos)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month